Familial hematuric syndromes - Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes

Contributions to Nephrology

Volumn 136, Issue , 2001, Pages 79-99

  Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

BASEMENT MEMBRANE; GENETIC LINKAGE; GENETICS; GLOMERULUS; HEARING IMPAIRMENT; HEMATURIA; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; NEPHRITIS; PATHOLOGY; REVIEW; THROMBOCYTOPENIA;

BASEMENT MEMBRANE; COLLAGEN TYPE IV; DEAFNESS; HEMATURIA; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE; KIDNEY GLOMERULUS; LINKAGE (GENETICS); NEPHRITIS, HEREDITARY; THROMBOCYTOPENIA;

EID: 0035537907     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (106)

1. Waldherr R: Familial glomerular disease. Contrib Nephrol. Basel, Karger, 1982, vol 33, pp 104-121.
2. Coppo R, Gianoglio B, Porcellini MG, Maringhini S: Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Nephrol Dial Transplant 1998;13:293-297.
3. Piqueras AI, White RH, Raafat F, Moghal N, Milford DV: Renal biopsy diagnosis in children presenting with hematuria. Pediatr Nephrol 1998;12:386-391.
4. Lang S, Stevenson B, Risdon RA: Thin basement membrane nephropathy as a cause of recurrent haematuria in childhood. Histopathology 1990;16:331-337.
5. Trachtman H, Weiss R, Bennett B, Griefer I: Isolated hematuria in children: Indications for a renal biopsy. Kidney Int 1984;25:94-99.
6. Schroder CH, Bontemps CM, Assmann KJM, Schuurmans-Stekhoven JH, Foidart JM, Monnens LAH, Veerkamp JH: Renal biopsy and family studies in 65 children with isolated hematuria. Acta Paediatr Scand 1990;79:630-636.
7. Olson DL, Anand SK, Landing BH, Heuser E, Grushkin CM, Lieberman E: Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodies. J Pediatr 1980;96:697-699.
8. McCoy RC, Johnson HK, Stone WJ, Wilson CB: Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 1982;21:642-652.
9. Kashtan C, Fish AJ, Kleppel M, Yoshioka K, Michael AF: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 1986;78:1035-1044.
10. Wieslander J, Barr JF, Butkowski R, Edwards SJ, Bygren P, Heinegard D, Hudson BG: Goodpasture antigen of the glomerular basement membrane: Localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA 1984;81:3838-3842.
11. Atkin CL, Hasstedt SJ, Menlove L, Cannon L, Kirschner N, Schwartz C, Nguyen K, Skolnick M: Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 1988;42: 249-255.
12. Kleppel MM, Kashtan CE, Butkowski RJ, Fish AJ, Michael AF: Alport familial nephritis: Absence of 28 kilodalton non-collagenous monomers of type IV collagen in glomerular basement membrane. J Clin Invest 1987;80:263-266.
13. Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K: Identification of a distinct type IV collagen a chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 1990;87: 1606-1610.
14. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990;248:1224-1227.
15. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, PirsonY, Verellen-Dumoulin C, Chan B, Schroeder CH, Smeets HJM, Reeders ST: Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994;8:77-82.
16. Gregory MC, Atkin CL: Alport syndrome; in Schrier RW, Gottschalk CW (eds): Diseases of the Kidney. Boston, Little Brown, 1993, pp 571-591.
17. Zhou J, Ding M, Zhao Z, Reeders ST: Complete primary structure of the sixth chain of human basement membrane collagen, α6(IV). J Biol Chem 1994;269:13193-13199.
18. Boyd CD, Toth-Fejel S, Gadi IK, Litt M, Condon MR, Kolbe M, Hagen IK, Kurkinen M, MacKenzie JW, Magenis E: The genes coding for human pro-α1(IV) and pro-α2(IV) collagen are both located at the end of the long arm of chromosome 13. Am J Hum Genet 1988;42:309-314.
19. Mariyama M, Zheng K, Yang-Feng TL, Reeders ST: Colocalization of the genes for the α3(IV) and α4(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics 1992;13: 809-813.
20. Sugimoto M, Oohashi T, Ninomiya Y: The genes COL4A5 and COL4A6, coding for basement membrane collagen chains α5(IV) and α6(IV), are located head-to-head in close proximity on human chromosome Xq22 and COL4A6 is transcribed from two alternative promoters. Proc Natl Acad Sci USA 1994;91:11679-11683.
21. Boutaud A, Borza DB, Bondar O, Gunwar S, Netzer KO, Singh N, Ninomiya Y, Sado Y, Noelken ME, Hudson BG: Type IV collagen of the glomerular basement membrane: Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem 2000;275:30716-30724.
22. Lemmink HH, Schröder CH, Monnens LAH, Smeets HJM: The clinical spectrum of type IV collagen mutations. Hum Mutat 1997;9:477-499.
23. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC: X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000; 11:649-657.
24. Antignac C, Zhou J, Sanak M, Cochat P, Roussel B, Deschenes G, Gros F, Knebelmann B, Hors-Cayla MC, Tryggvason K, Gubler MC: Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 gene. Kidney Int 1992;42:1178-1183.
25. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, de Paepe A, Tryggvason K, Reeders ST: Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 1993;261:1167-1169.
26. Heidet L, Dahan K, Zhou J, Xu Z, Cochat P, Gould JDM, Leppig KA, Proesmans W, Guyot C, Guillot M, Roussel B, Tryggvason K, Grunfeld JP, Gubler MC, Antignac C: Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumors. Hum Mol Genet 1995;4:99-108.
27. Heidet L, Cohen-Solal L, Boye E, Thorner P, Kemper MJ, David A, Larget Piet L, Zhou J, Flinter F, Zhang X, Gubler MC, Antignac C: Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define theDL critical region. Cytogenet Cell Genet 1997;78:240-246.
28. Segal Y, Peissel B, Renieri A, de Marchi M, Ballabio A, Pei Y, Zhou J: LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis. Am J Hum Genet 1999;64:62-69.
29. Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Grohagenriska C, Neumann HPH, Trembath R, Tryggvason K: Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: A study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol 1996;7:702-709.
30. Piez KA: Molecular and aggregate structures of the collagens; in Piez KA, Reddi AH (eds): Extracellular Matrix Biochemistry. New York, Elsevier, 1984, pp 1-39.
31. Kuvaniemi H, Tromp G, Prockop DJ: Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IV), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 1997;9:300-315.
32. Prockop DJ: Mutations in collagen genes as a cause of connective-tissue diseases. N Engl J Med 1992;326:540-546.
33. Lemmink HH, Mochizuki T, van den Heuvel LPWJ, Schroder CH, Barrientos A, Monnens LAH, van Oost BA, Brunner HG, Reeders ST, Smeets HJM: Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 1994;3: 1269-1273.
34. Knebelmann B, Forestier L, Drouot L, Quinones S, Chuet C, Benessy F, Saus J, Antignac C: Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 1995;4:675-679.
35. Ding J, Stitzel J, Berry P, Hawkins E, Kashtan C: Autosomal recessive Alport syndrome: Mutation in the COL4A3 gene in a woman with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 1995;5:1714-1717.
36. Heidet L, Arrondel C, Forestier L, Cohen-Solal L, Mollet G, Gutierrez B, Stavrou C, Gubler MC, Antignac C: Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 2001;12:97-106.
37. Boye E, Mollet GF, Cohen-Solal L, Heidet L, Cochat P, Grunfeld JP, Palcoux JB, Gubler MC, Antignac C: Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 1998;63:1329-1340.
38. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP: Genetic heterogeneity of Alport syndrome. Kidney Int 1985;27:672-677.
39. Van der Loop FTL, Heidet L, Timmer EDJ, van den Bosch BJC, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LAH, Schroder CH, Smeets HJM: Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 2000;58:1870-1875.
40. Renieri A, Meroni M, Sessa A, Battini G, Serbelloni P, Torri-Tarelli L, Seri M, Galli L, De Marchi M: Variability of clinical phenotype in a large Alport family with gly l143-ser change of collagen α5(IV) chain. Nephron 1994;67:444-449.
41. Pochet JM, Bobrie G, Landais P, Goldfarb B, Grunfeld JP: Renal prognosis in Alport's and related syndromes: Influence of the mode of inheritance. Nephrol Dial Transplant 1989;4:1016-1021.
42. Gubler M, Levy M, Broyer M, Naizot C, Gonzales G, Perrin D, Habib R: Alport's syndrome: A report of 58 cases and a review of the literature. Am J Med 1981;70:493-505.
43. Pajari H, Setala K, Heiskari N, Kaarianen H, Rosenlof K, Koskimies O: Ocular findings in 34 patients with Alport syndrome: Correlation of the findings to mutations in COL4A5 gene. Acta Ophthalmol Scand 1999;77:214-217.
44. Colville DJ, Savige J: Alport syndrome: A review of the ocular manifestations. Ophthalmic Genet 1997;18:161-173.
45. Colville D, Savige J, Morfis M, Ellis J, Kerr P, Agar J, Fasset R: Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet 1997;18:119-128.
46. Nielsen CE: Lenticonus anterior and Alport's syndrome. Arch Ophthalmol 1978;56:518-530.
47. Brownell RD, Wolter JR: Anterior lenticonus in familial hemorrhagic nephritis: Demonstration of lens pathology. Arch Ophthalmol 1964;71:481-483.
48. Streeten BW, Robinson MR, Wallace R, Jones DB: Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 1987;105:1693-1697.
49. KatoT, WatanabeY, Nakayasu K, Kanai A, YajimaY: The ultrastructure of the lens capsule abnormalities in Alport's syndrome. Jpn J Ophthalmol 1998;42:401-405.
50. Perrin D, Jungers P, Grunfeld JP, Delons S, Noel LH, Zenatti C: Perimacular changes in Alport's syndrome. Clin Nephrol 1980; 13:163-167.
51. Sabates R, Krachmer JH, Weingeist TA: Ocular findings in Alport's syndrome. Ophthalmologica 1983;186:204-210.
52. Thompson SM, Deady JP, Willshaw HE, White RHR: Ocular signs in Alport's syndrome. Eye 1987;1:146-153.
53. Teekhasaenee C, Nimmanit S, Wutthiphan S, Vareesangthip K, Laohapand T, Malasitr P, Ritch R: Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology 1991;98:1207-1215.
54. Rhys C, Snyers B, Pirson Y: Recurrent corneal erosion associated with Alport's syndrome. Kidney Int 1997;52:208-211.
55. Burke JP, Clearkin LG, Talbot JF: Recurrent corneal epithelial erosions in Alport's syndrome. Acta Ophthalmol 1991;69:555-557.
56. Antignac C, Heidet L: Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. Contrib Nephrol. Basel, Karger, 1996, vol 117, pp 172-182.
57. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y: Immunohistochemical study of a 1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 1994;46:1413-1421.
58. Kashtan CE, Kleppel MM, Gubler MC: Immunohistologic findings in Alport syndrome. Contrib Nephrol. Basel, Karger, 1996, vol 117, pp 142-153.
59. Kagawa M, Kishiro Y, Naito I, Nemoto T, Nakanishi H, Ninomiya Y, Sado Y: Epitope-defined monoclonal antibodies against type-IV collagen for diagnosis of Alport's syndrome. Nephrol Dial Transpl 1997;12:1238-1241.
60. Meleg-Smith S, Magliato S, Cheles M, Garola RE, Kashtan CE: X-linked Alport syndrome in females. Hum Pathol 1998;29:404-408.
61. Gubler MC, Knebelmann B, Beziau A, Broyer M, PirsonY, Haddoum F, Kleppel MM, Antignac C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 1995;47:1142-1147.
62. Hinglais N, Grunfeld JP, Bois LE: Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest 1972;27: 473-487.
63. Spear GS, Slusser RJ: Alport's syndrome: Emphasizing electron microscopic studies of the glomerulus. Am J, Pathol 1972;69:213-222.
64. Churg J, Sherman RL: Pathologic characteristics of hereditary nephritis. Arch Pathol 1973;95: 374-379.
65. Rumpelt HJ: Alport's syndrome: Specificity and pathogenesis of glomerular basement membrane alterations. Pediatr Nephrol 1987;l:422-427.
66. Jansen B, Thorner P, Baumal R, Valu V, Maxie MG, Singh A: Samoyed hereditary glomerulopathy (SHG): Evolution of splitting of glomerular capillary basement membranes. Am J Pathol 1986; 125:536-545.
67. Rumpelt HJ: Hereditary nephropathy (Alport syndrome): Correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 1980;13:203-207.
68. Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras J, Druout L, Deschennes G, Grunfeld JP, Broyer M, Gubler MC, Antignac C: Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 1996;59:1221-1232.
69. Kashtan CE, McEnery PT, Tejani A, Stablein DM: Renal allograft survival according to primary diagnosis: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1995;9:679-684.
70. Kashtan CE: Alport syndrome: An inherited disorder of renal, ocular and cochlear basement membranes. Medicine 1999;78:338-360.
71. Tryggvason K, Heikkila P, Pettersson E, Tibell A, Thorner P: Can Alport syndrome be treated by gene therapy? Kidney Int 1997;52:1493-1499.
72. Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter BV, Valli VE, Jacobs RM: Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme inhibitor. J Comp Pathol 1997;117:209-225.
73. Callis L, Vila A, Carrera M, Nieto J: Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int 1999;55:1051-1056.
74. Callis L, Vila A, Nieto J, Fortuny G: Effect of cyclosporin A on proteinuria in patients with Alport's syndrome. Pediatr Nephrol 1992;6:140-144.
75. Mazzucco G, Barsotti P, Muda AO, Fortunato M, Mihatsch M, Torri-Tarelli L, Renieri A, Faraggiana T, De Marchi M, Monga G: Ultrastructural and immunohistochemical findings in Alport's syndrome: A study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 1988;9:1023-1031.
76. Pajari H, Sinkkonen J: Psychosocial impact of an X-linked hereditary disease: A study of Alport syndrome patients and family members. Child Care Health Dev 2000;26:239-250.
77. Van der Loop FTL, Monnens LAH, Schroder CH, Lemmink HH, Breuning MH, Timmer EDJ, Smeets HJM: Identification of COL4A5 defects in Alport syndrome by immunochemistry of skin. Kidney Int 1999;55:1217-1224.
78. Lees G, Helman RG, Kashtan CE, Michael AF, Homco LD, Millichamp NJ, Ninomiya Y, Sado Y, Kim Y: A model of autosomal recessive Alport syndrome in English cocker spaniel dogs. Kidney Int 1998;54:706-719.
79. Lees G, Helman RG, Kashtan CE, Michael AF, Homco LD, Millichamp NJ, Camacho ZT, Templeton JW, Ninomiya Y, Sado Y, Kim Y: A new form of X-linked dominant hereditary nephritis in dogs. Am J Vet Res 1999;60:373-383.
80. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 1996; 10:2981-2992.
81. Zheng K, Thorner PS, Marrano P, Baumal R, McInnes RR: Canine X-chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV Proc Natl Acad Sci USA 1994;91:3989-3993.
82. Lu W, Phillips CL, Killen PD, Hlaing T, Harrison WR, Elder FFB, Miner JH, Overbeek P, Meisler MH: Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. Genomics 1999;61:113-124.
83. Hood JC, Savige J, Hendtlass A, Kleppel MM, Huxtable CR, Robinson WF: Bull terrier hereditary nephritis: A model for autosomal dominant Alport syndrome. Kidney Int 1995;47:758-765.
84. Miner JJ, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen a3(IV): Implications for Alport syndrome. J Cell Biol 1996; 135:1403-1413.
85. Valli VEO, Baumal R, Thorner P, Jacobs R, Marrano P, Davies C, Qizilbash B, Clarke H: Dietary modification reduces splitting of glomerular basement membranes and delays death due to renal failure in canine X-linked hereditary nephritis. Lab Invest 1991;65:67-73.
86. Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D: Role for transforming growth factor-βl in Alport renal disease progression. Kidney Int 1999;56:1662-1673.
87. Heikkila P, Tryggvason K, Thorner P: Animal models of Alport syndrome: advancing the prospects for effective human gene therapy. Exp Nephrol 2000;8:1-7.
88. Blumenthal SS, Fritsche C, Lemann J: Establishing the diagnosis of benign familial hematuria: The importance of examining the urine sediment of family members. JAMA 1988;259:2263-2266.
89. Lemmink HH, Nillesen WN, Mochizuki T, Schröder CH, Brunner HG, van Oost BA, Monnens LAH, Smeets HJM: Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 1996;98:1114-1118.
90. Piccini M, Casari G, Zhou J, Bruttini M, Volti SL, Ballabio A, Renieri A: Evidence for genetic heterogeneity in benign familial hematuria. Am J Nephrol 1999;19:464-467.
91. Dische FE, Weston MJ, Parsons V: Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults. Am J Nephrol 1985;5:103-109.
92. Tiebosch ATMG, Frederik PM, van Breda Vriesman PJC, Mooy JMV, van Rie H, van de Wiel TWM, Wolters J, Zeppenfeldt E: Thin-basement-membrane nephropathy in adults with persistent hematuria. N Engl J Med 1989;320:14-18.
93. Nieuwhof CM, de Heer F, de Leeuw P, van Breda Vriesman PJ: Thin GBM nephropathy: Premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 1997;51:1596-1601.
94. Cosio FG, Falkenhain ME, Sedmak DD: Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 1994;46:471-474.
95. Vogler C, McAdams AJ, Homan SM: Glomerular basement membrane and lamina densa in infants and children: An ultrastructural evaluation. Pediatr Pathol 1987;7:527-534.
96. Steffes MW, Barbosa J, Basgen JM, Sutherland DER, Najarian JS, Mauer SM: Quantitative glomerular morphology of the normal human kidney. Kidney Int 1983;49:82-86.
97. Dische FE: Measurement of glomerular basement membrane thickness and its application to the diagnosis of thin-membrane nephropathy. Arch Pathol Lab Med 1992;116:43-49.
98. Milanesi C, Rizzoni G, Braggion F, Galdiolo D: Electron microscopy for measurement of glomerular basement membrane width in children with benign familial hematuria. Appl Pathol 1984;2:199-204.
99. Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernfield MR, Kushner JH, Ablin AR: Hereditary macrothrombocytopenia, nephritis and deafness. Am J Med 1972;52:299-310.
100. Peterson LC, Rao KV, Crosson JT, White JG: Fechtner syndrome: A variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopathia. Blood 1985;65:397-406.
101. Clare NM, Montiel MM, Lifschitz MD, Bannayan GA: Alport's syndrome associated with macrothrombocytopenic thrombocytopenia. Am J Clin Pathol 1979;72:111-117.
102. Naito I, Nomura S, Inoue S, Kagawa M, Kawai S, GunshinY, Joh K, Tsukidate C, Sado Y, Osawa G: Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome. J Clin Pathol 1997;50:919-922.
103. Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Frok-Simoni F, Pras E, Rechavi G: Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q l1-13. Am J Hum Genet 1999;65:1711-1717.
104. Toren A, Rozenfeld-Granot G, Rocca B, Epstein CJ, Amariglio N, Laghi F, Landolfi R, Brok-Simoni F, Carlsson LE, Rechavi G, Greinacher A: Autosomal-dominant giant platelet syndromes: A hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q l1-13. Blood 2000;96:3447-3451.
105. The May-Hegglin/Fechtner Syndrome Consortium: Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 2000;26:103-105.
106. Lalwani AK, Goldstein JA, Kelley MJ, Luxford W, Castelein CM, Mhatre AN: Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000;67:1121-1128.